True Wealth Design, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1966033 AKRON, OH

Position in REGN

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$130,943

-$38,265 QoQ

Shares Held

210

-4.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#1,075

of 1,322 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

True Wealth Design, LLC holds $1,417,706 across 151 Biotechnology names. REGN ranks #3 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,850	$209,716
2	EXEL	Exelixis, Inc.	2,973	$161,760
3	REGN	Regeneron Pharmaceuticals, Inc. This page	210	$130,943
4	RPRX	Royalty Pharma plc	1,644	$92,179
5	VRTX	Vertex Pharmaceuticals Inc / Ma	173	$85,934
6	JAZZ	Jazz Pharmaceuticals plc	320	$77,110
7	BMRN	Biomarin Pharmaceutical Inc	957	$54,759
8	CORT	Corcept Therapeutics Inc	529	$45,996

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$130,943	210	-4.1%	Shares	Sole	2026-07-16
2026-03-31	$169,208	219	+34.4%	Shares	Sole	2026-04-13
2025-12-31	$125,814	163	+30.4%	Shares	Sole	2026-01-08
2025-09-30	$70,283	125	+1685.7%	Shares	Sole	2025-10-21
2025-06-30	$3,675	7	-41.7%	Shares	Sole	2025-08-06
2025-03-31	$7,610	12	+500.0%	Shares	Sole	2025-05-13
2024-12-31	$1,424	2	-33.3%	Shares	Sole	2025-02-14
2024-09-30	$3,153	3	0.0%	Shares	Sole	2024-11-14
2024-06-30	$3,153	3	+50.0%	Shares	Sole	2024-08-14
2024-03-31	$1,924	2	+100.0%	Shares	Sole	2024-05-14
2023-12-31	$878	1	-50.0%	Shares	Sole	2024-02-14
2023-09-30	$1,645	2	0.0%	Shares	Sole	2023-11-13
2023-06-30	$1,437	2	0.0%	Shares	Sole	2023-08-14
2023-03-31	$1,643	2	-99.8%	Shares	Sole	2023-05-12
2022-12-31	$814,562	1,129	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.